SGBY News 01/09/2017 - 0.025
Post# of 273249
(Total Views: 1045)
Posted On: 01/09/2017 6:58:35 PM
Signal Bay, Inc. $SGBY News
Last updated 01/09/2017 - 0.025
Seven Signal Bay Clients Get Maryland Marijuana Moving
Dec 14, 2016
OTC Disclosure & News Service
-
Seven Signal Bay Clients Get Maryland Marijuana Moving
PR Newswire
BEND, OR, Dec. 14, 2016
BEND, OR, Dec. 14, 2016 /PRNewswire/ - Signal Bay (OTCQB: SGBY) is proud to announce that seven of its Maryland clients received Stage One license pre-approvals, more than a year after applications were submitted.
The Maryland Medical Cannabis Commission ("MMCC"
named 102 dispensary entities last Friday who have each been awarded Stage One license pre-approvals from a total of 811 submitted.
The seven prospective licensees cover districts ranging from the College Park, Baltimore City and County, as well as Frederick and Washington Counties.
Lori Glauser, company COO and head of the Signal Bay Services division stated "Seven of the eight clients who engaged Signal Bay Services are now proceeding with the final stages of the state licensing process. Only two coveted licenses were available in each district and as many as 25 applications were received in each district and the competition was significant.
Signal Bay anticipates assisting the applicants as they proceed with final licensing and move into the build and operations phase. The company is already working closely with BluPharms, LLC, a dispensary that plans to operate near the University of Maryland.
Ms. Glauser continued "I cannot be more grateful to all of the Signal Bay staff and consultants who made this happen. Top notch professionals, including Dr. Alicia Wilbur, author of Medical Marijuana Desk Reference, and nearly a dozen other experts from across the country, worked around the clock on behalf of our clients during the very short window of application last year."
Will Waldrop, CEO of Signal Bay concluded, "While we have moved swiftly into the cannabis testing space during the past year with our expansion of EVIO Labs from Oregon and into California, we continue to provide consulting services to the industry, which complements the expansion of EVIO Labs. Our consulting services are evolving and expanding from application and startup support to regulatory R&D, product formulation, and operational optimization. While awaiting the results of the Maryland applications, we acquired 4 additional cannabis test labs in Oregon and California, and helped over a dozen Oregon companies attain cultivation, dispensary, and processing licenses. Several of those consulting clients are now testing with EVIO."
About Signal Bay, Inc.: Signal Bay, Inc. is an Oregon-based Life Sciences company. Through its three subsidiaries: EVIO Labs, Signal Bay Research and Signal Bay Services; the Company provides research, consulting services, and analytical testing services to the legal cannabis industry. The Company's EVIO Labs division operates state-of-the-art testing facilities and offers accredited testing methodologies performed by a qualified team of scientists to ensure the safety and quality of the nation's cannabis supply. Learn more at http://SignalBay.com or the company can be reached directly @ 1-888-544-EVIO.
This news release contains "forward-looking statements" as that term is defined in Section 27(a) of the Securities Act of 1933, as amended, and Section 21(e) of the Securities Exchange Act of 1934, as amended. Statements may contain certain forward-looking statements pertaining to future anticipated or projected plans, performance and developments, as well as other statements relating to future operations and results. Any statements in this press release that are not statements of historical fact may be considered to be forward-looking statements. Words such as "may," "will," "expect," "believe," "anticipate," "estimate," "intends," "goal," "objective," "seek," "attempt," or variations of these or similar words, identify forward-looking statements. These forward-looking statements by their nature are estimates of future results only and involve substantial risks and uncertainties, including but not limited to risks associated with the uncertainty of future financial results, additional financing requirements, development of new products, our ability to complete our product testing and launch our product commercially, the acceptance of our product in the marketplace, the uncertainty of the laws and regulations relating to cannabis, the impact of competitive products or pricing, technological changes, the effect of economic conditions and other uncertainties detailed from time to time in our reports filed with the Securities and Exchange Commission, available at www.sec.gov or https://signalbay.com/investors.
SOURCE Signal Bay, Inc.
Copyright © 2016 PR Newswire. All Rights Reserved
The above news release has been provided by the above company via the OTC Disclosure and News Service. Issuers of news releases and not OTC Markets Group Inc. are solely responsible for the accuracy of such news releases.
Signal Bay Reports New Record Revenues for November
Dec 08, 2016
OTC Disclosure & News Service
-
Bend, Oregon, Dec. 08, 2016 (GLOBE NEWSWIRE) -- Signal Bay, Inc. (OTCQB: SGBY) the market leader in cannabis quality control testing and laboratory services announced today that the company achieved record sales growth for the second month in a row. The November 2016 revenues exceeded the record setting cash flow announced last month by over 50%.
CEO William Waldrop stated, "In conjunction with the new Oregon regulatory environment and the fall cannabis harvest, we are continuing to see increased testing revenues for our EVIO Labs Division. For the month of November, the company set another record month generating over $345,000 in revenue.” These revenue numbers are preliminary and have not yet been audited or reported in accordance with GAAP standards.
Signal Bay operates state-of-the-art testing facilities and offers accredited testing methodologies that ensure the safety and potency of the nation's cannabis supply through its’ EVIO Labs division. As the legalization of medical and recreational marijuana sweeps across the country, demand for reliable, independent cannabis quality control testing facilities is increasing dramatically nationwide.
Mr. Waldrop added, “The Company is continuing to acquire equipment and expand our hub & spoke service offerings to meet the needs of the growing Oregon Market. The Oregon Liquor Control Commission (OLCC) distributed a letter last week stating they are working on over 900 pending applications for producers, processors and dispensaries. The Company is motivated by the recent rule changes impacting testing requirements in Oregon. The new Oregon Health Authority temporary testing rules allow for smaller cultivators and processors to now economically participate in the marketplace whereas two months ago, the cost of testing was a barrier to entry.
About Signal Bay, Inc.: Signal Bay, Inc. is an Oregon-based Life Sciences company. Through its three subsidiaries: EVIO Labs, Signal Bay Research and Signal Bay Services; the Company provides research, consulting services, and analytical testing services to the legal cannabis industry. The Company's EVIO Labs division operates state-of-the-art testing facilities and offers accredited testing methodologies performed by a qualified team of scientists to ensure the safety and quality of the nation's cannabis supply. Learn more at http://SignalBay.com or the company can be reached directly @ 1-888-544-EVIO.
This news release contains "forward-looking statements" as that term is defined in Section 27(a) of the Securities Act of 1933, as amended, and Section 21(e) of the Securities Exchange Act of 1934, as amended. Statements may contain certain forward-looking statements pertaining to future anticipated or projected plans, performance and developments, as well as other statements relating to future operations and results. Any statements in this press release that are not statements of historical fact may be considered to be forward-looking statements. Words such as "may," "will," "expect," "believe," "anticipate," "estimate," "intends," "goal," "objective," "seek," "attempt," or variations of these or similar words, identify forward-looking statements. These forward-looking statements by their nature are estimates of future results only and involve substantial risks and uncertainties, including but not limited to risks associated with the uncertainty of future financial results, additional financing requirements, development of new products, our ability to complete our product testing and launch our product commercially, the acceptance of our product in the marketplace, the uncertainty of the laws and regulations relating to cannabis, the impact of competitive products or pricing, technological changes, the effect of economic conditions and other uncertainties detailed from time to time in our reports filed with the Securities and Exchange Commission, available at www.sec.gov or https://signalbay.com/investors.
Investor Contact:
William Waldrop, CEO
william@signalbay.com
(541) 633-4568
Copyright © 2016 GlobeNewswire. All Rights Reserved
The above news release has been provided by the above company via the OTC Disclosure and News Service. Issuers of news releases and not OTC Markets Group Inc. are solely responsible for the accuracy of such news releases.
Signal Bay to Highlight Very Successful 2016 at the LD Microchip Conference
Nov 30, 2016
OTC Disclosure & News Service
-
Signal Bay to Highlight Very Successful 2016 at the LD Microchip Conference
PR Newswire
BEND, OR, Nov. 30, 2016
The Company to Also Lay Out Its Aggressive Growth Strategy for 2017
BEND, OR, Nov. 30, 2016 /PRNewswire/ - Signal Bay (OTCQB:SGBY) will be presenting at the widely-attended LD Microchip Conference, which is to be held in Luxe Sunset Bel Air in Los Angeles from December 6 through December 8. Marcum and SEG will be the main sponsors of this significant industry event, and event which will host thousands of investors and 240 small and micro-cap companies.
Signal Bay operates state-of-the-art testing facilities and offers accredited testing methodologies that ensure the safety and potency of the nation's cannabis supply through its' EVIO Labs division. As the legalization of medical and recreational marijuana sweeps across the country, demand for reliable, independent cannabis quality control testing facilities is increasing dramatically.
The self-described "Woodstock" of Microcap, LD Micro was founded in 2006 with the sole purpose of being an independent resource in the microcap space. What started out as a newsletter highlighting unique companies has transformed into an event platform hosting several influential conferences annually.
Signal Bay to Focus Presentation on Rapid Industry Changes and Its Rapid Sales Growth
The election results in California and other states was nothing short of a game-changer for the legal cannabis market, which is now the fastest growing industry in the nation.
A subset of the overall marijuana market is the cannabis testing market, a space that is expected to grow exponentially as cannabis transitions from a formerly illegal substance to a legal and regulated consumer product. The testing market in the United States is expected to balloon to $850 million in size by 2020. In California alone, the market is expected to reach $300 million in 2017. Cannabis testing is critical to ensuring that cannabis, whether for medical or recreational use, is safe from pesticides, E. coli, molds, solvents and other toxins and impurities.
"We are looking forward to presenting at the LD Microchip Conference during such an exciting time in our industry," commented CEO of Signal Bay, William Waldrop. "The year 2016 will go on record as the year in which the cannabis industry began on an explosive growth trajectory of historic proportions. We are truly entering in to a "Green Rush." In addition, we also strongly believe that the cannabis testing subset is the most attractive, risk averse subset of the cannabis industry, generally. As leading player in this space, we are very pleased and excited to share significant progress we have achieved in 2016 as well as our aggressive growth strategy going forward into 2017. We look forward to sharing our past successes and future plans with current and potential investors at next week's widely attended and publicized conference."
While many cannabis testing companies are currently vying for market share in the wide open markets resulting the recent election, strict regulations and mandatory cannabis testing accreditation have made it difficult for many inexperienced cannabis testing companies to survive. Signal Bay, however, is the dominant player in Oregon where its EVIO Labs are the currently accredited and setting the standard in the industry. Signal Bay currently has five EVIO Labs in operation including one in California. The Company plans to add 18 more accredited EVIO Labs in the Golden State by the end of 2018. Signal Bay has seen explosive growth over the last few months, and just recently reported record sales figures for the month of October. The presentation could not come at a more exciting time for the Company, or for the industry. The Company projects to generate over $45 million in annual revenues and operate over 30 EVIO Labs by 2020.
Signal Bay to Also Highlight Its Scientific Edge Over Competitors
Many Cannabis testing labs struggle to survive simply because they lack proper technical expertise. This is not the case for Signal Bay, whose strength comes from its deep bullpen of experienced team members. Some of the 31 Signal Bay team members helping the growing company execute on its aggressive growth strategy include Chief Science Officer and natural products researcher, Dr. Anthony Smith. A well-respected biochemist and researcher with a PhD in Molecular and Cellular Biology from Oregon State University. Dr. Smith held a position on the Oregon governor's Task Force for Researching the Medical and Public Health Effects of Cannabis and serves on the scientific advisory board of the Health Research Institute, a non-profit horticultural and medical research group. Dr. Smith is just player in what the Company believes is the strongest and most experienced management team in the industry.
"Lacking the scientific expertise and experience, many labs take up to a year to reach some level of accreditation, but fail to become fully accredited and remain unable to provide the full suite of services required for regulatory compliance," Waldrop commented.
"Many get stuck in the research and development stage after accreditation. At Signal Bay, however, our advanced technical experience as well as our experience and understanding of the regulatory system, enables us to get our EVIO Labs accredited and fully operational in a matter of months, rather than years. This efficiency enables us to grow quickly and to meet our ambitious milestones we have set for the coming year, milestones I look forward to laying out next week at the LD Microcap Conference in Los Angeles."
Legal Disclaimer: Financial Press Media Group, Inc. is not registered with any financial or securities regulatory authority and does not provide, nor claims to provide, investment advice or recommendations to readers of this release to buy, sell or hold any securities. Investing intrinsically involves substantial risk and readers are reminded to consult an investment professional and complete their own due diligence, including SEC filings, when researching any companies mentioned in this release. This release is based upon publicly available information and, while vetted, is not considered to be all-inclusive or guaranteed to be free from errors. With respect to Section 17(
of the Securities Act of 1933 and in the interest of full disclosure, we call the reader's attention to the fact that Financial Press Media Group, Inc. may have received compensation from the companies mentioned in this release.
SOURCE Signal Bay, Inc.
Copyright © 2016 PR Newswire. All Rights Reserved
The above news release has been provided by the above company via the OTC Disclosure and News Service. Issuers of news releases and not OTC Markets Group Inc. are solely responsible for the accuracy of such news releases.
Signal Bay Reports Record Revenues for October
Nov 17, 2016
OTC Disclosure & News Service
-
Las Vegas, Nevada, Nov. 17, 2016 (GLOBE NEWSWIRE) -- Signal Bay, Inc. (OTCQB: SGBY) the market leader in cannabis quality control testing and laboratory services announced today that the company achieved record sales growth for the month of October, 2016.
CEO William Waldrop stated, "Operating within the new Oregon regulatory environment which commenced October 1, 2016, EVIO Labs has seen a tremendous increase in the number of accounts and variety of tests being processed across the board at all four of our Oregon cannabis testing laboratories. The growth has been incredible and I personally could not be more proud of our team for the way they’ve stepped up to meet demand. For the month of October, the company generated over $198,000 in revenue.” These revenue numbers are preliminary and have not yet been audited or reported in accordance with GAAP standards.
Signal Bay operates state-of-the-art testing facilities and offers accredited testing methodologies that ensure the safety and potency of the nation's cannabis supply through its’ EVIO Labs division. As the legalization of medical and recreational marijuana sweeps across the country, demand for reliable, independent cannabis quality control testing facilities is increasing dramatically.
Mr. Waldrop added, “We are confident that the revenue results for November will be much higher as more edible and extract processors are entering the market. The forward looking number based on October results is a very conservative number as it includes only 11 days of operations for our Portland location and our first California EVIO Labs facility did not begin registering sales as part of Signal Bay until November.”
Mr. Waldrop concluded, "The election results in California were a huge positive for our industry and we feel strongly that our continued expansion into this state will be favorable as a result. We are now up to 31 total team members working to build our business and our EVIO Labs brand and I’d like to thank them once again for their amazing efforts to date. We are fast approaching a cash flow positive status and it is due entirely to the teams hard work and dedication to clean cannabis products.”
About Signal Bay, Inc.: Signal Bay, Inc. is an Oregon-based Life Sciences company. Through its three subsidiaries: Signal Bay Research, Signal Bay Services and EVIO Labs; the Company provides research, consulting services, and analytical testing services to the legal cannabis industry. The Company's EVIO Labs division operates state-of-the-art testing facilities and offers accredited testing methodologies performed by a qualified team of scientists to ensure the safety and quality of the nation's cannabis supply. Learn more at http://SignalBay.com or the company can be reached directly @ 1-888-544-EVIO.
This news release contains "forward-looking statements" as that term is defined in Section 27(a) of the Securities Act of 1933, as amended, and Section 21(e) of the Securities Exchange Act of 1934, as amended. Statements may contain certain forward-looking statements pertaining to future anticipated or projected plans, performance and developments, as well as other statements relating to future operations and results. Any statements in this press release that are not statements of historical fact may be considered to be forward-looking statements. Words such as "may," "will," "expect," "believe," "anticipate," "estimate," "intends," "goal," "objective," "seek," "attempt," or variations of these or similar words, identify forward-looking statements. These forward-looking statements by their nature are estimates of future results only and involve substantial risks and uncertainties, including but not limited to risks associated with the uncertainty of future financial results, additional financing requirements, development of new products, our ability to complete our product testing and launch our product commercially, the acceptance of our product in the marketplace, the uncertainty of the laws and regulations relating to cannabis, the impact of competitive products or pricing, technological changes, the effect of economic conditions and other uncertainties detailed from time to time in our reports filed with the Securities and Exchange Commission, available at www.sec.gov or https://signalbay.com/investors.
Investor Contact:
William Waldrop, CEO
william@signalbay.com
(541) 633-4568
Copyright © 2016 GlobeNewswire. All Rights Reserved
The above news release has been provided by the above company via the OTC Disclosure and News Service. Issuers of news releases and not OTC Markets Group Inc. are solely responsible for the accuracy of such news releases.
Signal Bay Appoints New CFO and Uplists to the OTCQB Venture Marketplace
Nov 14, 2016
OTC Disclosure & News Service
-
Bend, Oregon, Nov. 14, 2016 (GLOBE NEWSWIRE) -- Signal Bay, Inc. (OTCQB: SGBY) a Life Science company and the market leader in cannabis testing and laboratory services is pleased to announce that the Company has been uplisted and approved for trading on the OTCQB Marketplace for early stage and developing U.S. and international companies. The company has also engaged and appointed Christian Carnell, CPA as Chief Financial Officer (CFO).
"With this successful uplist the company is now strategically positioned on the OTCQB Venture Marketplace. We believe that the increased transparency, reporting standards, management certification and compliance requirements of the OTCQB that are representative of our commitment to our shareholders will result in greater liquidity and investor awareness of the Company’s business model" stated CEO William Waldrop.
"This is a validation of the companies continued progress in achieving milestones set out in our business plan" continued Mr. Waldrop, "The Merrill Lynch Research Report “High POTential” on Cannabis Life Science companies published in 2015 identified Signal Bay as a "leading provider" of cannabis lab testing services and opened a lot of eyes in the retail and institutional investor communities to our potential and we are confident this uplist will bring an even deeper level of investor interest and awareness that will benefit the company and our shareholders in the long term".
Signal Bays’ new CFO, Christian Carnell, holds a Bachelor’s degree in accounting from the University of Utah and is a Certified Public Accountant licensed through the state of California. He has over ten years of experience in auditing, accounting and financial reporting and has previously worked with over fifty public issuers providing accounting, financial statement preparation and other general business services on a contract basis.
Mr. Carnell stated “It is a tremendous opportunity to join Signal Bay at such an exciting time. I'm looking forward to helping Signal Bay succeed in the next phases of its growth initiatives and supporting the already tremendous leadership team in place.”
About Signal Bay, Inc.: Signal Bay, Inc. is the Oregon-based Life Sciences company. Through its three subsidiaries: Signal Bay Research, Signal Bay Services and EVIO Labs; the Company provides research, consulting services, and analytical testing services to the legal cannabis industry. The Company's EVIO Labs division operates state-of-the-art testing facilities and offers accredited testing methodologies performed by a qualified team of scientists to ensure the safety and quality of the nation's cannabis supply. Learn more at http://SignalBay.com or the company can be reached directly @ 1-888-544-EVIO.
This news release contains "forward-looking statements" as that term is defined in Section 27(a) of the Securities Act of 1933, as amended, and Section 21(e) of the Securities Exchange Act of 1934, as amended. Statements may contain certain forward-looking statements pertaining to future anticipated or projected plans, performance and developments, as well as other statements relating to future operations and results. Any statements in this press release that are not statements of historical fact may be considered to be forward-looking statements. Words such as "may," "will," "expect," "believe," "anticipate," "estimate," "intends," "goal," "objective," "seek," "attempt," or variations of these or similar words, identify forward-looking statements. These forward-looking statements by their nature are estimates of future results only and involve substantial risks and uncertainties, including but not limited to risks associated with the uncertainty of future financial results, additional financing requirements, development of new products, our ability to complete our product testing and launch our product commercially, the acceptance of our product in the marketplace, the uncertainty of the laws and regulations relating to cannabis, the impact of competitive products or pricing, technological changes, the effect of economic conditions and other uncertainties detailed from time to time in our reports filed with the Securities and Exchange Commission, available at www.sec.gov or https://signalbay.com/investors.
Investor Contact:
William Waldrop, CEO
william@signalbay.com
(541) 633-4568
Copyright © 2016 GlobeNewswire. All Rights Reserved
The above news release has been provided by the above company via the OTC Disclosure and News Service. Issuers of news releases and not OTC Markets Group Inc. are solely responsible for the accuracy of such news releases.
OTC Markets Group Welcomes Newly Verified OTCQB Companies – November 11
Nov 11, 2016
OTC Disclosure & News Service
New York, NY -
OTC Markets Group Inc. (OTCQX: OTCM), operator of financial markets for 10,000 U.S. and global securities, today announced the following companies are verified for trading on the OTCQB® Venture Market:
Blue Spa, Inc. (OTCQB: BUES) â Blue Spa Incorporated was incorporated in the State of Nevada, USA on September 4, 2009. The Company is in its early developmental stage since its formation and has not realized any revenues from its planned operations. The Company was engaged in the development of an internet based retailer of a multi-channel concept combining a wholesale distribution with a retail strategy relating to the quality personal care products, fitness apparel and related accessories. The Company obtained a majority vote from its shareholders to amend the âs name from Blue Spa Incorporated to Sustainable Petroleum Group Inc. to better reflect the new direction it plans to undertake in the oil and gas business. The name change will be effected on or around November 22, 2016 or as soon as practicable, pending regulatory approval.
Signal Bay, Inc. (OTCQB: SGBY) â Signal Bay, Inc. is the Oregon-based Life Sciences company. Through its three subsidiaries: Signal Bay Research, Signal Bay Services and EVIO Labs; the Company provides research, consulting services, and analytical testing services to the legal cannabis industry. The Company's EVIO Labs division operates state-of-the-art testing facilities and offers accredited testing methodologies performed by a qualified team of scientists to ensure the safety and quality of the nation's cannabis supply. As the legalization of medical and recreational marijuana continues across the country, demand for reliable cannabis testing facilities is increasing.
U.S. investors can find current financial disclosure and Real-Time Level 2 quotes for these companies on www.otcmarkets.com.
About OTC Markets Group Inc.
OTC Markets Group Inc. (OTCQX: OTCM) operates the OTCQX® Best Market, the OTCQB® Venture Market, and the Pink® Open Market for 10,000 U.S. and global securities. Through OTC Link® ATS, we connect a diverse network of broker-dealers that provide liquidity and execution services. We enable investors to easily trade through the broker of their choice and empower companies to improve the quality of information available for investors.
To learn more about how we create better informed and more efficient markets, visit www.otcmarkets.com.
OTC Link ATS is operated by OTC Link LLC, member FINRA/SIPC and SEC regulated ATS.
Subscribe to the OTC Markets RSS Feed
Copyright © 2016 OTC Markets. All Rights Reserved
Last updated 01/09/2017 - 0.025
Seven Signal Bay Clients Get Maryland Marijuana Moving
Dec 14, 2016
OTC Disclosure & News Service
-
Seven Signal Bay Clients Get Maryland Marijuana Moving
PR Newswire
BEND, OR, Dec. 14, 2016
BEND, OR, Dec. 14, 2016 /PRNewswire/ - Signal Bay (OTCQB: SGBY) is proud to announce that seven of its Maryland clients received Stage One license pre-approvals, more than a year after applications were submitted.
The Maryland Medical Cannabis Commission ("MMCC"
named 102 dispensary entities last Friday who have each been awarded Stage One license pre-approvals from a total of 811 submitted. The seven prospective licensees cover districts ranging from the College Park, Baltimore City and County, as well as Frederick and Washington Counties.
Lori Glauser, company COO and head of the Signal Bay Services division stated "Seven of the eight clients who engaged Signal Bay Services are now proceeding with the final stages of the state licensing process. Only two coveted licenses were available in each district and as many as 25 applications were received in each district and the competition was significant.
Signal Bay anticipates assisting the applicants as they proceed with final licensing and move into the build and operations phase. The company is already working closely with BluPharms, LLC, a dispensary that plans to operate near the University of Maryland.
Ms. Glauser continued "I cannot be more grateful to all of the Signal Bay staff and consultants who made this happen. Top notch professionals, including Dr. Alicia Wilbur, author of Medical Marijuana Desk Reference, and nearly a dozen other experts from across the country, worked around the clock on behalf of our clients during the very short window of application last year."
Will Waldrop, CEO of Signal Bay concluded, "While we have moved swiftly into the cannabis testing space during the past year with our expansion of EVIO Labs from Oregon and into California, we continue to provide consulting services to the industry, which complements the expansion of EVIO Labs. Our consulting services are evolving and expanding from application and startup support to regulatory R&D, product formulation, and operational optimization. While awaiting the results of the Maryland applications, we acquired 4 additional cannabis test labs in Oregon and California, and helped over a dozen Oregon companies attain cultivation, dispensary, and processing licenses. Several of those consulting clients are now testing with EVIO."
About Signal Bay, Inc.: Signal Bay, Inc. is an Oregon-based Life Sciences company. Through its three subsidiaries: EVIO Labs, Signal Bay Research and Signal Bay Services; the Company provides research, consulting services, and analytical testing services to the legal cannabis industry. The Company's EVIO Labs division operates state-of-the-art testing facilities and offers accredited testing methodologies performed by a qualified team of scientists to ensure the safety and quality of the nation's cannabis supply. Learn more at http://SignalBay.com or the company can be reached directly @ 1-888-544-EVIO.
This news release contains "forward-looking statements" as that term is defined in Section 27(a) of the Securities Act of 1933, as amended, and Section 21(e) of the Securities Exchange Act of 1934, as amended. Statements may contain certain forward-looking statements pertaining to future anticipated or projected plans, performance and developments, as well as other statements relating to future operations and results. Any statements in this press release that are not statements of historical fact may be considered to be forward-looking statements. Words such as "may," "will," "expect," "believe," "anticipate," "estimate," "intends," "goal," "objective," "seek," "attempt," or variations of these or similar words, identify forward-looking statements. These forward-looking statements by their nature are estimates of future results only and involve substantial risks and uncertainties, including but not limited to risks associated with the uncertainty of future financial results, additional financing requirements, development of new products, our ability to complete our product testing and launch our product commercially, the acceptance of our product in the marketplace, the uncertainty of the laws and regulations relating to cannabis, the impact of competitive products or pricing, technological changes, the effect of economic conditions and other uncertainties detailed from time to time in our reports filed with the Securities and Exchange Commission, available at www.sec.gov or https://signalbay.com/investors.
SOURCE Signal Bay, Inc.
Copyright © 2016 PR Newswire. All Rights Reserved
The above news release has been provided by the above company via the OTC Disclosure and News Service. Issuers of news releases and not OTC Markets Group Inc. are solely responsible for the accuracy of such news releases.
Signal Bay Reports New Record Revenues for November
Dec 08, 2016
OTC Disclosure & News Service
-
Bend, Oregon, Dec. 08, 2016 (GLOBE NEWSWIRE) -- Signal Bay, Inc. (OTCQB: SGBY) the market leader in cannabis quality control testing and laboratory services announced today that the company achieved record sales growth for the second month in a row. The November 2016 revenues exceeded the record setting cash flow announced last month by over 50%.
CEO William Waldrop stated, "In conjunction with the new Oregon regulatory environment and the fall cannabis harvest, we are continuing to see increased testing revenues for our EVIO Labs Division. For the month of November, the company set another record month generating over $345,000 in revenue.” These revenue numbers are preliminary and have not yet been audited or reported in accordance with GAAP standards.
Signal Bay operates state-of-the-art testing facilities and offers accredited testing methodologies that ensure the safety and potency of the nation's cannabis supply through its’ EVIO Labs division. As the legalization of medical and recreational marijuana sweeps across the country, demand for reliable, independent cannabis quality control testing facilities is increasing dramatically nationwide.
Mr. Waldrop added, “The Company is continuing to acquire equipment and expand our hub & spoke service offerings to meet the needs of the growing Oregon Market. The Oregon Liquor Control Commission (OLCC) distributed a letter last week stating they are working on over 900 pending applications for producers, processors and dispensaries. The Company is motivated by the recent rule changes impacting testing requirements in Oregon. The new Oregon Health Authority temporary testing rules allow for smaller cultivators and processors to now economically participate in the marketplace whereas two months ago, the cost of testing was a barrier to entry.
About Signal Bay, Inc.: Signal Bay, Inc. is an Oregon-based Life Sciences company. Through its three subsidiaries: EVIO Labs, Signal Bay Research and Signal Bay Services; the Company provides research, consulting services, and analytical testing services to the legal cannabis industry. The Company's EVIO Labs division operates state-of-the-art testing facilities and offers accredited testing methodologies performed by a qualified team of scientists to ensure the safety and quality of the nation's cannabis supply. Learn more at http://SignalBay.com or the company can be reached directly @ 1-888-544-EVIO.
This news release contains "forward-looking statements" as that term is defined in Section 27(a) of the Securities Act of 1933, as amended, and Section 21(e) of the Securities Exchange Act of 1934, as amended. Statements may contain certain forward-looking statements pertaining to future anticipated or projected plans, performance and developments, as well as other statements relating to future operations and results. Any statements in this press release that are not statements of historical fact may be considered to be forward-looking statements. Words such as "may," "will," "expect," "believe," "anticipate," "estimate," "intends," "goal," "objective," "seek," "attempt," or variations of these or similar words, identify forward-looking statements. These forward-looking statements by their nature are estimates of future results only and involve substantial risks and uncertainties, including but not limited to risks associated with the uncertainty of future financial results, additional financing requirements, development of new products, our ability to complete our product testing and launch our product commercially, the acceptance of our product in the marketplace, the uncertainty of the laws and regulations relating to cannabis, the impact of competitive products or pricing, technological changes, the effect of economic conditions and other uncertainties detailed from time to time in our reports filed with the Securities and Exchange Commission, available at www.sec.gov or https://signalbay.com/investors.
Investor Contact:
William Waldrop, CEO
william@signalbay.com
(541) 633-4568
Copyright © 2016 GlobeNewswire. All Rights Reserved
The above news release has been provided by the above company via the OTC Disclosure and News Service. Issuers of news releases and not OTC Markets Group Inc. are solely responsible for the accuracy of such news releases.
Signal Bay to Highlight Very Successful 2016 at the LD Microchip Conference
Nov 30, 2016
OTC Disclosure & News Service
-
Signal Bay to Highlight Very Successful 2016 at the LD Microchip Conference
PR Newswire
BEND, OR, Nov. 30, 2016
The Company to Also Lay Out Its Aggressive Growth Strategy for 2017
BEND, OR, Nov. 30, 2016 /PRNewswire/ - Signal Bay (OTCQB:SGBY) will be presenting at the widely-attended LD Microchip Conference, which is to be held in Luxe Sunset Bel Air in Los Angeles from December 6 through December 8. Marcum and SEG will be the main sponsors of this significant industry event, and event which will host thousands of investors and 240 small and micro-cap companies.
Signal Bay operates state-of-the-art testing facilities and offers accredited testing methodologies that ensure the safety and potency of the nation's cannabis supply through its' EVIO Labs division. As the legalization of medical and recreational marijuana sweeps across the country, demand for reliable, independent cannabis quality control testing facilities is increasing dramatically.
The self-described "Woodstock" of Microcap, LD Micro was founded in 2006 with the sole purpose of being an independent resource in the microcap space. What started out as a newsletter highlighting unique companies has transformed into an event platform hosting several influential conferences annually.
Signal Bay to Focus Presentation on Rapid Industry Changes and Its Rapid Sales Growth
The election results in California and other states was nothing short of a game-changer for the legal cannabis market, which is now the fastest growing industry in the nation.
A subset of the overall marijuana market is the cannabis testing market, a space that is expected to grow exponentially as cannabis transitions from a formerly illegal substance to a legal and regulated consumer product. The testing market in the United States is expected to balloon to $850 million in size by 2020. In California alone, the market is expected to reach $300 million in 2017. Cannabis testing is critical to ensuring that cannabis, whether for medical or recreational use, is safe from pesticides, E. coli, molds, solvents and other toxins and impurities.
"We are looking forward to presenting at the LD Microchip Conference during such an exciting time in our industry," commented CEO of Signal Bay, William Waldrop. "The year 2016 will go on record as the year in which the cannabis industry began on an explosive growth trajectory of historic proportions. We are truly entering in to a "Green Rush." In addition, we also strongly believe that the cannabis testing subset is the most attractive, risk averse subset of the cannabis industry, generally. As leading player in this space, we are very pleased and excited to share significant progress we have achieved in 2016 as well as our aggressive growth strategy going forward into 2017. We look forward to sharing our past successes and future plans with current and potential investors at next week's widely attended and publicized conference."
While many cannabis testing companies are currently vying for market share in the wide open markets resulting the recent election, strict regulations and mandatory cannabis testing accreditation have made it difficult for many inexperienced cannabis testing companies to survive. Signal Bay, however, is the dominant player in Oregon where its EVIO Labs are the currently accredited and setting the standard in the industry. Signal Bay currently has five EVIO Labs in operation including one in California. The Company plans to add 18 more accredited EVIO Labs in the Golden State by the end of 2018. Signal Bay has seen explosive growth over the last few months, and just recently reported record sales figures for the month of October. The presentation could not come at a more exciting time for the Company, or for the industry. The Company projects to generate over $45 million in annual revenues and operate over 30 EVIO Labs by 2020.
Signal Bay to Also Highlight Its Scientific Edge Over Competitors
Many Cannabis testing labs struggle to survive simply because they lack proper technical expertise. This is not the case for Signal Bay, whose strength comes from its deep bullpen of experienced team members. Some of the 31 Signal Bay team members helping the growing company execute on its aggressive growth strategy include Chief Science Officer and natural products researcher, Dr. Anthony Smith. A well-respected biochemist and researcher with a PhD in Molecular and Cellular Biology from Oregon State University. Dr. Smith held a position on the Oregon governor's Task Force for Researching the Medical and Public Health Effects of Cannabis and serves on the scientific advisory board of the Health Research Institute, a non-profit horticultural and medical research group. Dr. Smith is just player in what the Company believes is the strongest and most experienced management team in the industry.
"Lacking the scientific expertise and experience, many labs take up to a year to reach some level of accreditation, but fail to become fully accredited and remain unable to provide the full suite of services required for regulatory compliance," Waldrop commented.
"Many get stuck in the research and development stage after accreditation. At Signal Bay, however, our advanced technical experience as well as our experience and understanding of the regulatory system, enables us to get our EVIO Labs accredited and fully operational in a matter of months, rather than years. This efficiency enables us to grow quickly and to meet our ambitious milestones we have set for the coming year, milestones I look forward to laying out next week at the LD Microcap Conference in Los Angeles."
Legal Disclaimer: Financial Press Media Group, Inc. is not registered with any financial or securities regulatory authority and does not provide, nor claims to provide, investment advice or recommendations to readers of this release to buy, sell or hold any securities. Investing intrinsically involves substantial risk and readers are reminded to consult an investment professional and complete their own due diligence, including SEC filings, when researching any companies mentioned in this release. This release is based upon publicly available information and, while vetted, is not considered to be all-inclusive or guaranteed to be free from errors. With respect to Section 17(
of the Securities Act of 1933 and in the interest of full disclosure, we call the reader's attention to the fact that Financial Press Media Group, Inc. may have received compensation from the companies mentioned in this release. SOURCE Signal Bay, Inc.
Copyright © 2016 PR Newswire. All Rights Reserved
The above news release has been provided by the above company via the OTC Disclosure and News Service. Issuers of news releases and not OTC Markets Group Inc. are solely responsible for the accuracy of such news releases.
Signal Bay Reports Record Revenues for October
Nov 17, 2016
OTC Disclosure & News Service
-
Las Vegas, Nevada, Nov. 17, 2016 (GLOBE NEWSWIRE) -- Signal Bay, Inc. (OTCQB: SGBY) the market leader in cannabis quality control testing and laboratory services announced today that the company achieved record sales growth for the month of October, 2016.
CEO William Waldrop stated, "Operating within the new Oregon regulatory environment which commenced October 1, 2016, EVIO Labs has seen a tremendous increase in the number of accounts and variety of tests being processed across the board at all four of our Oregon cannabis testing laboratories. The growth has been incredible and I personally could not be more proud of our team for the way they’ve stepped up to meet demand. For the month of October, the company generated over $198,000 in revenue.” These revenue numbers are preliminary and have not yet been audited or reported in accordance with GAAP standards.
Signal Bay operates state-of-the-art testing facilities and offers accredited testing methodologies that ensure the safety and potency of the nation's cannabis supply through its’ EVIO Labs division. As the legalization of medical and recreational marijuana sweeps across the country, demand for reliable, independent cannabis quality control testing facilities is increasing dramatically.
Mr. Waldrop added, “We are confident that the revenue results for November will be much higher as more edible and extract processors are entering the market. The forward looking number based on October results is a very conservative number as it includes only 11 days of operations for our Portland location and our first California EVIO Labs facility did not begin registering sales as part of Signal Bay until November.”
Mr. Waldrop concluded, "The election results in California were a huge positive for our industry and we feel strongly that our continued expansion into this state will be favorable as a result. We are now up to 31 total team members working to build our business and our EVIO Labs brand and I’d like to thank them once again for their amazing efforts to date. We are fast approaching a cash flow positive status and it is due entirely to the teams hard work and dedication to clean cannabis products.”
About Signal Bay, Inc.: Signal Bay, Inc. is an Oregon-based Life Sciences company. Through its three subsidiaries: Signal Bay Research, Signal Bay Services and EVIO Labs; the Company provides research, consulting services, and analytical testing services to the legal cannabis industry. The Company's EVIO Labs division operates state-of-the-art testing facilities and offers accredited testing methodologies performed by a qualified team of scientists to ensure the safety and quality of the nation's cannabis supply. Learn more at http://SignalBay.com or the company can be reached directly @ 1-888-544-EVIO.
This news release contains "forward-looking statements" as that term is defined in Section 27(a) of the Securities Act of 1933, as amended, and Section 21(e) of the Securities Exchange Act of 1934, as amended. Statements may contain certain forward-looking statements pertaining to future anticipated or projected plans, performance and developments, as well as other statements relating to future operations and results. Any statements in this press release that are not statements of historical fact may be considered to be forward-looking statements. Words such as "may," "will," "expect," "believe," "anticipate," "estimate," "intends," "goal," "objective," "seek," "attempt," or variations of these or similar words, identify forward-looking statements. These forward-looking statements by their nature are estimates of future results only and involve substantial risks and uncertainties, including but not limited to risks associated with the uncertainty of future financial results, additional financing requirements, development of new products, our ability to complete our product testing and launch our product commercially, the acceptance of our product in the marketplace, the uncertainty of the laws and regulations relating to cannabis, the impact of competitive products or pricing, technological changes, the effect of economic conditions and other uncertainties detailed from time to time in our reports filed with the Securities and Exchange Commission, available at www.sec.gov or https://signalbay.com/investors.
Investor Contact:
William Waldrop, CEO
william@signalbay.com
(541) 633-4568
Copyright © 2016 GlobeNewswire. All Rights Reserved
The above news release has been provided by the above company via the OTC Disclosure and News Service. Issuers of news releases and not OTC Markets Group Inc. are solely responsible for the accuracy of such news releases.
Signal Bay Appoints New CFO and Uplists to the OTCQB Venture Marketplace
Nov 14, 2016
OTC Disclosure & News Service
-
Bend, Oregon, Nov. 14, 2016 (GLOBE NEWSWIRE) -- Signal Bay, Inc. (OTCQB: SGBY) a Life Science company and the market leader in cannabis testing and laboratory services is pleased to announce that the Company has been uplisted and approved for trading on the OTCQB Marketplace for early stage and developing U.S. and international companies. The company has also engaged and appointed Christian Carnell, CPA as Chief Financial Officer (CFO).
"With this successful uplist the company is now strategically positioned on the OTCQB Venture Marketplace. We believe that the increased transparency, reporting standards, management certification and compliance requirements of the OTCQB that are representative of our commitment to our shareholders will result in greater liquidity and investor awareness of the Company’s business model" stated CEO William Waldrop.
"This is a validation of the companies continued progress in achieving milestones set out in our business plan" continued Mr. Waldrop, "The Merrill Lynch Research Report “High POTential” on Cannabis Life Science companies published in 2015 identified Signal Bay as a "leading provider" of cannabis lab testing services and opened a lot of eyes in the retail and institutional investor communities to our potential and we are confident this uplist will bring an even deeper level of investor interest and awareness that will benefit the company and our shareholders in the long term".
Signal Bays’ new CFO, Christian Carnell, holds a Bachelor’s degree in accounting from the University of Utah and is a Certified Public Accountant licensed through the state of California. He has over ten years of experience in auditing, accounting and financial reporting and has previously worked with over fifty public issuers providing accounting, financial statement preparation and other general business services on a contract basis.
Mr. Carnell stated “It is a tremendous opportunity to join Signal Bay at such an exciting time. I'm looking forward to helping Signal Bay succeed in the next phases of its growth initiatives and supporting the already tremendous leadership team in place.”
About Signal Bay, Inc.: Signal Bay, Inc. is the Oregon-based Life Sciences company. Through its three subsidiaries: Signal Bay Research, Signal Bay Services and EVIO Labs; the Company provides research, consulting services, and analytical testing services to the legal cannabis industry. The Company's EVIO Labs division operates state-of-the-art testing facilities and offers accredited testing methodologies performed by a qualified team of scientists to ensure the safety and quality of the nation's cannabis supply. Learn more at http://SignalBay.com or the company can be reached directly @ 1-888-544-EVIO.
This news release contains "forward-looking statements" as that term is defined in Section 27(a) of the Securities Act of 1933, as amended, and Section 21(e) of the Securities Exchange Act of 1934, as amended. Statements may contain certain forward-looking statements pertaining to future anticipated or projected plans, performance and developments, as well as other statements relating to future operations and results. Any statements in this press release that are not statements of historical fact may be considered to be forward-looking statements. Words such as "may," "will," "expect," "believe," "anticipate," "estimate," "intends," "goal," "objective," "seek," "attempt," or variations of these or similar words, identify forward-looking statements. These forward-looking statements by their nature are estimates of future results only and involve substantial risks and uncertainties, including but not limited to risks associated with the uncertainty of future financial results, additional financing requirements, development of new products, our ability to complete our product testing and launch our product commercially, the acceptance of our product in the marketplace, the uncertainty of the laws and regulations relating to cannabis, the impact of competitive products or pricing, technological changes, the effect of economic conditions and other uncertainties detailed from time to time in our reports filed with the Securities and Exchange Commission, available at www.sec.gov or https://signalbay.com/investors.
Investor Contact:
William Waldrop, CEO
william@signalbay.com
(541) 633-4568
Copyright © 2016 GlobeNewswire. All Rights Reserved
The above news release has been provided by the above company via the OTC Disclosure and News Service. Issuers of news releases and not OTC Markets Group Inc. are solely responsible for the accuracy of such news releases.
OTC Markets Group Welcomes Newly Verified OTCQB Companies – November 11
Nov 11, 2016
OTC Disclosure & News Service
New York, NY -
OTC Markets Group Inc. (OTCQX: OTCM), operator of financial markets for 10,000 U.S. and global securities, today announced the following companies are verified for trading on the OTCQB® Venture Market:
Blue Spa, Inc. (OTCQB: BUES) â Blue Spa Incorporated was incorporated in the State of Nevada, USA on September 4, 2009. The Company is in its early developmental stage since its formation and has not realized any revenues from its planned operations. The Company was engaged in the development of an internet based retailer of a multi-channel concept combining a wholesale distribution with a retail strategy relating to the quality personal care products, fitness apparel and related accessories. The Company obtained a majority vote from its shareholders to amend the âs name from Blue Spa Incorporated to Sustainable Petroleum Group Inc. to better reflect the new direction it plans to undertake in the oil and gas business. The name change will be effected on or around November 22, 2016 or as soon as practicable, pending regulatory approval.
Signal Bay, Inc. (OTCQB: SGBY) â Signal Bay, Inc. is the Oregon-based Life Sciences company. Through its three subsidiaries: Signal Bay Research, Signal Bay Services and EVIO Labs; the Company provides research, consulting services, and analytical testing services to the legal cannabis industry. The Company's EVIO Labs division operates state-of-the-art testing facilities and offers accredited testing methodologies performed by a qualified team of scientists to ensure the safety and quality of the nation's cannabis supply. As the legalization of medical and recreational marijuana continues across the country, demand for reliable cannabis testing facilities is increasing.
U.S. investors can find current financial disclosure and Real-Time Level 2 quotes for these companies on www.otcmarkets.com.
About OTC Markets Group Inc.
OTC Markets Group Inc. (OTCQX: OTCM) operates the OTCQX® Best Market, the OTCQB® Venture Market, and the Pink® Open Market for 10,000 U.S. and global securities. Through OTC Link® ATS, we connect a diverse network of broker-dealers that provide liquidity and execution services. We enable investors to easily trade through the broker of their choice and empower companies to improve the quality of information available for investors.
To learn more about how we create better informed and more efficient markets, visit www.otcmarkets.com.
OTC Link ATS is operated by OTC Link LLC, member FINRA/SIPC and SEC regulated ATS.
Subscribe to the OTC Markets RSS Feed
Copyright © 2016 OTC Markets. All Rights Reserved
(0)
(0)Scroll down for more posts ▼